Harold Leever Regl Cancer Center is categorized under in Waterbury, CT and active since 1999.
Harold Leever Regl Cancer Center was established in 1999, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact Deborah Parkinson, Manager at the company’s single location by writing to 1075 Chase Parkway, Waterbury, Connecticut CT 06708 or by phoning (203) 575-5555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Harold Leever Regl Cancer Center |
Contact Person: | Deborah Parkinson, Manager |
Address: | 1075 Chase Parkway, Waterbury, Connecticut 06708 |
Phone Number: | (203) 575-5555 |
Website Address: | leevercancercenter.org |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | |
SIC Code: | 8069 |
NAICS Code: | 6223100 |
Share This Business: |
Harold Leever Regl Cancer Center was started in 1999 to provide professional under the SIC code 8069 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Deborah Parkinson, Manager for inquiries that concern Harold Leever Regl Cancer Center by calling the company number (203) 575-5555, as your correspondence is most welcome. Additionally, the physical location of the single location of Harold Leever Regl Cancer Center can be found at the coordinates 41.5419,-73.08072 as well as the street address 1075 Chase Parkway in Waterbury, Connecticut 06708.
For its online presence, you may visit Harold Leever Regl Cancer Center’s website at leevercancercenter.org and engage with its social media outlets through on Twitter and on Facebook.